Holen Sie sich die Stockscreener-App
8.59
3.91%
-0.35
Handel nachbörslich:
8.50
-0.09
-1.05%
Finanzdaten der Immix Biopharma Inc-Aktie (IMMX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
14.06%
7.6625
|
6.7177 | 4.6829 | 4.9871 | 7.3949 |
| Operating Income/Loss |
14.06%
-7.6625
|
-6.7177 | -4.6829 | -4.9871 | -7.3949 |
| Nonoperating Income/Loss |
18.76%
0.0845
|
0.1041 | 0.1502 | 0.1859 | 0.2567 |
| Income/Loss From Continuing Operations Before Tax |
14.58%
-7.578
|
-6.6136 | -4.5327 | -4.8013 | -7.1383 |
| Income Tax Expense/Benefit |
13.37%
0.00772
|
0.00891 | 0.00982 | 0.0108 | 0.0111 |
| Income/Loss From Continuing Operations After Tax |
14.54%
-7.5857
|
-6.6226 | -4.5425 | -4.8121 | -7.1494 |
|
Net Income/Loss
|
14.54%
-7.5857
|
-6.6226 | -4.5425 | -4.8121 | -7.1494 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
6.48%
31.93
|
29.98 | 29.70 | 0.4261 | 29.42 |
| Diluted Average Shares |
6.48%
31.93
|
29.98 | 29.70 | 0.4261 | 29.42 |
| Basic Earnings Per Share |
9.09%
-0.24
|
-0.22 | -0.15 | -0.16 | -0.24 |
| Diluted Earnings Per Share |
9.09%
-0.24
|
-0.22 | -0.15 | -0.16 | -0.24 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):